Alembic Pharmaceuticals Dividend
Dividend criteria checks 4/6
Alembic Pharmaceuticals is a dividend paying company with a current yield of 0.8% that is well covered by earnings.
Key information
0.8%
Dividend yield
27%
Payout ratio
| Industry average yield | 0.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | ₹30.03 |
| Dividend yield forecast in 3Y | 1.1% |
Recent dividend updates
Recent updates
Results: Alembic Pharmaceuticals Limited Exceeded Expectations And The Consensus Has Updated Its Estimates
Feb 08
Subdued Growth No Barrier To Alembic Pharmaceuticals Limited (NSE:APLLTD) With Shares Advancing 25%
Jan 21Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?
Jan 05Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Can Manage Its Debt Responsibly
Sep 27Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly
Jun 09A Look At The Fair Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)
Apr 13Is Alembic Pharmaceuticals (NSE:APLLTD) A Risky Investment?
Feb 22Alembic Pharmaceuticals Limited (NSE:APLLTD) Shares Could Be 21% Below Their Intrinsic Value Estimate
Jan 04We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Alembic Pharmaceuticals Limited's (NSE:APLLTD) CEO For Now
Nov 05Here's Why Alembic Pharmaceuticals (NSE:APLLTD) Has A Meaningful Debt Burden
Aug 10Estimating The Intrinsic Value Of Alembic Pharmaceuticals Limited (NSE:APLLTD)
Jul 20We Think Alembic Pharmaceuticals (NSE:APLLTD) Is Taking Some Risk With Its Debt
May 05Alembic Pharmaceuticals (NSE:APLLTD) Seems To Use Debt Quite Sensibly
Jan 17Are Alembic Pharmaceuticals Limited (NSE:APLLTD) Investors Paying Above The Intrinsic Value?
Dec 17These 4 Measures Indicate That Alembic Pharmaceuticals (NSE:APLLTD) Is Using Debt Reasonably Well
Sep 23Is There An Opportunity With Alembic Pharmaceuticals Limited's (NSE:APLLTD) 27% Undervaluation?
Sep 02Here's Why I Think Alembic Pharmaceuticals (NSE:APLLTD) Might Deserve Your Attention Today
Jun 16Alembic Pharmaceuticals (NSE:APLLTD) Has A Pretty Healthy Balance Sheet
May 25Stability and Growth of Payments
Fetching dividends data
Stable Dividend: APLLTD's dividend payments have been volatile in the past 10 years.
Growing Dividend: APLLTD's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Alembic Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (APLLTD) | 0.8% |
| Market Bottom 25% (IN) | 0.3% |
| Market Top 25% (IN) | 1.2% |
| Industry Average (Pharmaceuticals) | 0.7% |
| Analyst forecast in 3 Years (APLLTD) | 1.1% |
Notable Dividend: APLLTD's dividend (0.8%) is higher than the bottom 25% of dividend payers in the Indian market (0.26%).
High Dividend: APLLTD's dividend (0.8%) is low compared to the top 25% of dividend payers in the Indian market (1.18%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (26.7%), APLLTD's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: At its current cash payout ratio (77%), APLLTD's dividend payments are covered by cash flows.